Litigation

Recent Posts

Supreme Court Won't Take Up Egregious Fraudulent Misjoinder In Hormone Cases
Posted on 12 Oct 2010 by Tom Moylan

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on Oct. 12 denied review of a circuit court ruling that 112 hormone replacement therapy (HRT) plaintiffs did not fraudulently misjoin nondiverse defendants in order to keep their cases in Minnesota... Read More

Tags: Solvay Pharmaceuticals Inc. , Wyeth , Judge William R. Wilson Jr. , Watson Laboratories Inc. , misjoinder , nondiverse defendants , HRT , personal injury , Wyeth v. Sandra Kirkland , Jurisdiction , Barr Laboratories Inc. , Novartis Pharmaceuticals Corp. , Litigation , Mead Johnson & Co. , multidistrict litigation , lawsuit , hormone replacement therapy , U.S. Supreme Court , Prempro , MDL , torts , In re: Prempro Products Liability Litigation

Failure-To-Update Claims For Generic Drugs Not Preempted In New Jersey, Court Says
Posted on 13 Nov 2014 by Tom Moylan

TRENTON, N.J. — (Mealey’s) A New Jersey state appeals court panel on Nov. 12 affirmed a lower court ruling that generic drug manufacturers can be sued for failure to update their labels with warnings added to the labels of the predecessor... Read More

Tags: preemption , Cornett v. Johnson & Johnson , Barr Pharmaceuticals LLC , Watson Laboratories Inc. , Food and Drug Administration , Mutual Pharmaceutical Co. Inc. , product liability , New Jersey , United Research Laboratories Inc. , FDA , In Re: Reglan Litigation , Fulgenzi v. PLIVA , Sixth Circuit , Pliva Inc. , heartburn drug , Litigation , Actavis Elizabeth LLC , Inc. v. Mensing , Pliva , failure to warn , generic drugs , Teva Pharmaceuticals USA Inc. , Fifth Circuit , metoclopramide , Reglan , torts